SCOPUS 정보 검색 플랫폼

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 882-884

REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study

(4) Coleman, Craig I a Antz, Matthias b Ehlken, Birgit c Evers, Thomas d

a UNIVERSITY OF CONNECTICUT (United States)

b KLINIKUM OLDENBURG (Germany)

c IQVIA (United States)

d BAYER PHARMA AG (Germany)

Author keywords

Anticoagulant; Non valvular atrial fibrillation; Rivaroxaban; Stroke; Vitamin k antagonist

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; PHENPROCOUMON; RIVAROXABAN; WARFARIN; BLOOD CLOTTING FACTOR 10A INHIBITOR;

ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHADS2 SCORE; COHORT ANALYSIS; COMORBIDITY; DESCRIPTIVE RESEARCH; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GERMANY; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; METHODOLOGY; OUTPATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC ERROR; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; AGED; COMPLICATION; FEMALE; MALE; STROKE;

AGED; ATRIAL FIBRILLATION; FACTOR XA INHIBITORS; FEMALE; HUMANS; MALE; STROKE;

EID: 84952700804 PISSN: 01675273 EISSN: 18741754 Source Type: Journal
DOI: 10.1016/j.ijcard.2015.09.037 Document Type: Article

Times cited : (44)

References (8)

1
- 80052592404
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
- M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, and R.M. Califf ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N. Engl. J. Med. 365 2011 883 891
- (2011) N. Engl. J. Med. , vol.365 , pp. 883-891
- Patel, M.R.¹ Mahaffey, K.W.² Garg, J.³ Pan, G.⁴ Singer, D.E.⁵ Hacke, W.⁶ Breithardt, G.⁷ Halperin, J.L.⁸ Hankey, G.J.⁹ Piccini, J.P.¹⁰ Becker, R.C.¹¹ Nessel, C.C.¹² Paolini, J.F.¹³ Berkowitz, S.D.¹⁴ Fox, K.A.¹⁵ Califf, R.M.¹⁶

2
- 84903592048
- Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
- F. Laliberté, M. Cloutier, W.W. Nelson, C.I. Coleman, D. Pilon, W.H. Olson, C.V. Damaraju, J.R. Schein, and P. Lefebvre Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients Curr. Med. Res. Opin. 30 2014 1317 1325
- (2014) Curr. Med. Res. Opin. , vol.30 , pp. 1317-1325
- Laliberté, F.¹ Cloutier, M.² Nelson, W.W.³ Coleman, C.I.⁴ Pilon, D.⁵ Olson, W.H.⁶ Damaraju, C.V.⁷ Schein, J.R.⁸ Lefebvre, P.⁹

3
- 70350741664
- Validity and representativeness of the ""Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies
- H. Becher, K. Kostev, and D. Schröder-Bernhardi Validity and representativeness of the ""Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies Int. J. Clin. Pharmacol. Ther. 47 2009 617 626
- (2009) Int. J. Clin. Pharmacol. Ther. , vol.47 , pp. 617-626
- Becher, H.¹ Kostev, K.² Schröder-Bernhardi, D.³

4
- 3543135271
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
- R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat. Med. 17 1998 2265 2281
- (1998) Stat. Med. , vol.17 , pp. 2265-2281
- D'Agostino, R.B.¹

5
- 70449641720
- Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research
- P.C. Austin Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research Commun. Stat. Simul. Comput. 38 2009 1228 1234
- (2009) Commun. Stat. Simul. Comput. , vol.38 , pp. 1228-1234
- Austin, P.C.¹

6
- 84878659651
- Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: Data from the ROCKET AF clinical trial
- D.E. Singer, A.S. Hellkamp, J.P. Piccini, K.W. Mahaffey, Y. Lokhnygina, G. Pan, J.L. Halperin, R.C. Becker, G. Breithardt, G.J. Hankey, W. Hacke, C.C. Nessel, M.R. Patel, R.M. Califf, and K.A. Fox ROCKET AF Investigators. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial J. Am. Heart Assoc. 2 1 2013 e000067
- (2013) J. Am. Heart Assoc. , vol.2 , Issue.1
- Singer, D.E.¹ Hellkamp, A.S.² Piccini, J.P.³ Mahaffey, K.W.⁴ Lokhnygina, Y.⁵ Pan, G.⁶ Halperin, J.L.⁷ Becker, R.C.⁸ Breithardt, G.⁹ Hankey, G.J.¹⁰ Hacke, W.¹¹ Nessel, C.C.¹² Patel, M.R.¹³ Califf, R.M.¹⁴ Fox, K.A.¹⁵

7
- 84904133274
- Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: A meta-analysis and meta-regression
- E.S. Mearns, C.M. White, C.G. Kohn, J. Hawthorne, J.S. Song, J. Meng, J.R. Schein, M.K. Raut, and C.I. Coleman Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression Thromb. J. 12 2014 14
- (2014) Thromb. J. , vol.12 , pp. 14
- Mearns, E.S.¹ White, C.M.² Kohn, C.G.³ Hawthorne, J.⁴ Song, J.S.⁵ Meng, J.⁶ Schein, J.R.⁷ Raut, M.K.⁸ Coleman, C.I.⁹

8
- 84884477193
- Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin
- M. Zalesak, K. Siu, K. Francis, C. Yu, H. Alvrtsyan, Y. Rao, D. Walker, S. Sander, G. Miyasato, D. Matchar, and H. Sanchez Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin Circ. Cardiovasc. Qual. Outcomes 6 2013 567 574
- (2013) Circ. Cardiovasc. Qual. Outcomes , vol.6 , pp. 567-574
- Zalesak, M.¹ Siu, K.² Francis, K.³ Yu, C.⁴ Alvrtsyan, H.⁵ Rao, Y.⁶ Walker, D.⁷ Sander, S.⁸ Miyasato, G.⁹ Matchar, D.¹⁰ Sanchez, H.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.